Coherus Oncology Inc (CHRS)

Operating Income

-$32.33M

Quarterly · Period ending: · USD

CHRS logo

CHRS Operating Income

Latest reported-$32.33M
CHRS Quarterly Operating Income (-$9.44M → -$32.33M)
High-resolution chart · PNG

CHRS operating income history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Operating Income — Quarterly (USD)
Period endingOperating Income (USD)
-32,331,000
-36,151,000
-45,880,000
-42,233,000
-45,486,000
-45,435,000
-42,246,000
-6,387,000
-20,509,000
-67,787,000
-68,905,000
-32,006,000
-34,543,000
-67,745,000
-51,493,000
-80,449,000
-44,013,000
-80,925,000
-39,547,000
-32,787,000
-24,164,000
-167,360,000
16,425,000
33,716,000
65,310,000
40,868,000
45,033,000
51,841,000
27,493,000
-16,599,000
-60,502,000
-56,972,000
-44,910,000
-42,032,000
-46,466,000
-56,615,000
-56,638,000
-72,417,000
-73,460,000
84,617,000
-62,736,000
-64,352,000
-52,207,000
-71,217,000
-58,895,000
-36,748,000
-26,560,000
-6,423,000
-17,938,000
-13,761,000
-10,487,000
-6,783,000
-9,284,000
-9,439,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.